TABLE OF ABBREVIATIONS
SUMMARY OF THE LEGAL ANALYSIS OF THE FIRST MEETING OF THE WORKING GROUP ON ACCESS TO GENETIC RESOURCES
1 INTRODUCTION
2 A BRIEF DESCRIPTION OF THE BONN MEETING
3 LOCATING GERMANY’S INTERESTS ON ACCESS AND BENEFIT SHARING
3.1 INDUSTRIAL INTERESTS
3.2 CONSERVATION OF BIOLOGICAL DIVERSITY
3.3 DEVELOPMENT COOPERATION
3.4 RESEARCH
4 A DETAILED ANALYSIS OF THE RESULTS OF THE BONN MEETING
4.1 DRAFT BONN GUIDELINES ON ACCESS TO GENETIC RESOURCES AND THE FAIR AND EQUITABLE SHARING OF THE BENEFITS ARISING OUT OF THEIR UTILIZATION
4.1.1 General Provisions (Section I)
4.1.2 Roles and Responsibilities of Users and Providers (Section II)
4.1.3 Participation of Stakeholders (Section III)
4.1.4 Steps in the ABS Process (Section IV)
4.1.5 Other Provisions (Section V)
4.2 ROLE OF INTELLECTUAL PROPERTY RIGHTS IN THE IMPLEMENTATION OF ACCESS AND BENEFIT-SHARING ARRANGEMENTS
4.2.1 Theme 1: Intellectual Property Rights that Support the objectives of the CBD
4.2.2 Theme 2: Intellectual property rights impede the objectives of the CBD
4.2.3 Theme 3: IPR Regimes and Problems with Patents
4.3 CAPACITY BUILDING
4.3.1 What are the objectives of the Action Plan?
4.3.2 Targets of capacity building measures
4.3.3 Who will provide capacity building?
4.3.4 What are the key areas requiring capacity building?
4.3.5 Processes to support the implementation of the Action Plan
4.3.6 What are the means of implementation?
4.3.7 How to co-ordinate capacity-building initiatives?
5 CONCLUDING REMARKS
BIBLIOGRAPHY